Training Details ASHM

Event

Event Name

Starting Date

Starting Time

Ending Date

Ending Time

Venue Time Zone

Event Status

Venue Name

City/Town/Suburb

Address

State

Course Summary

Synopsis


</br>
<p>Registration is FREE for GPs practicing in Australia.</p>

Event Description


</br>
<p>Direct-acting antiviral treatments for hepatitis C, which have very high cure rates and few or no side-effects, became available on the Pharmaceutical Benefits Scheme in March 2016. In the following two years, more than 58,000 people – 26% of the people living with chronic hepatitis C in Australia – initiated treatment, and the proportion of treatment prescribed by GPs increased dramatically from 8% to 38%.<sup>1</sup> However as of July 2018 there were still more than 170,000 people living with the virus, and treatment rates have declined after the initial high uptake.<sup>2</sup></p>
</br>
<p>For people living with hepatitis C, receiving treatment in familiar environments with their trusted, accessible, long-term doctors removes an important barrier to treatment. If hepatitis C is to be eliminated in Australia by 2030, more primary care practitioners will need to engage in hepatitis C testing and treatment as part of their core general practice work.</p>
</br>
<p>The <b>Treating Hepatitis C in General Practice Forum</b> is a rare opportunity for GPs to come together to share experiences and discuss innovative models of care. The theme <i>simple strategies, local solutions</i> will ensure GPs leave the forum with practical ideas they can implement and adapt to the needs of their local area. </p>
</br>
<p><i>The Treating Hepatitis C in General Practice Forum is run in partnership with, and is funded by, the Kirby Institute.</i></p>
</br> 
<p><a href="http://files.clickdimensions.com/ashmorgau-apflc/files/gpforum19.pdf?1552520147848" target="_blank">Download the event flyer here</a></p>
</br> 
<p><b>Registrations</b> </p>
<p>Registration cancellations and amendments must be notified in writing to ASHM. Cancellations received before 29 July 2019 will not incur a cancellation fee. Cancellations received in writing after 29 July 2019 will incur a $70 per day cancellation fee. This fee may be waived in exceptional circumstances at the discretion of ASHM. </p>
</br>
<p>As an alternative to cancellation, your registration may be transferred to another person without incurring any penalty. ASHM must be advised of the transfer in writing. Please email the name, position, phone and email address of the new delegate to education@ashm.org.au. </p>
</br>
<p>Registrations close Monday, 29 July 2019.</p>
</br>
<p><b>References </b></p>
<p>1. The Kirby Institute. Monitoring hepatitis C treatment uptake in Australia (Issue 9). The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia, July 2018 </p>
<p>2. The Kirby Institute. Decline in hepatitis C treatment uptake could threaten Australia’s elimination targets. The Kirby Institute, UNSW Sydney, Sydney, NSW, Australia, July 2018. </p>

Event Type

Reference Number

Training Details

Event

ASHM

Home

Community